Inhibikase Therapeutics Inc (IKT)
Operating Expenses
$21.05M
Quarterly · Period ending: · USD
IKT Operating Expenses
Latest reported$21.05Mperiod ending
Latest reported$21.05Mperiod ending
IKT Quarterly Operating Expenses ($169.78K → $21.05M)
Quarterly operating expenses
High-resolution chart · PNG
IKT operating expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Expenses (USD) |
|---|---|
| 21,050,995 | |
| 18,215,273 | |
| 13,775,626 | |
| 12,768,373 | |
| 10,832,278 | |
| 14,598,006 | |
| 12,922,133 | |
| 5,827,476 | |
| 5,050,535 | |
| 4,775,792 | |
| 4,396,999 | |
| 4,841,877 | |
| 6,159,607 | |
| 4,774,427 | |
| 4,393,498 | |
| 4,518,709 | |
| 1,664,308 | |
| 1,669,636 | |
| 1,653,147 | |
| 1,644,946 | |
| 1,608,972 | |
| 1,600,576 | |
| 1,144,319 | |
| 580,820 | |
| 370,331 | |
| 527,688 | |
| 394,624 | |
| 1,204,606 | |
| 2,338,612 | |
| 1,732,667 | |
| 2,604,149 | |
| 218,975 | |
| 743,487 | |
| 169,783 |